Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan
Toshihiko Masui(Kyoto University), Shinji Üemoto(Shiga University of Medical Science), Motohiro Sakamine(Translational Research Informatics Center (Japan)), Norihiro Kokudo(National Center for Global Health and Medicine), Akihiro Sakurai(Sapporo Medical University), Masanori Fukushima(Nagoya Institute of Technology), Yusuke Kinugasa(The Japanese Society of Gastroenterological Surgery), Kazuo Hara(Aichi Cancer Center), Shinsuke Kojima(Translational Research Informatics Center (Japan)), Yosuke Kasai(Kyoto University), Hiroshi Date(Kyoto University), Izumi Komoto(Kansai Electric Power (Japan)), Hiro‐o Yamano, Takuji Okusaka(National Cancer Centre Japan), Tetsuhide Ito, Susumu Hijioka(Aichi Cancer Center), Takashi Kikuchi, Koichi Hirata(Japan Coal Energy Center), Satoshi Hirano(Hokkaido University), Kenichi Sugihara(Toujinkai Hospital), Minoru Tanabe(Tokyo Institute of Technology), Atsushi Kudo(Tokyo Medical and Dental University), Ken Haruma(Kawasaki Medical School), Masayuki Imamura(Kansai Electric Power Hospital), Yasushi Ichikawa(Yokohama City University)
Cited by 16
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780